Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to ADAR1 Mutation

Case Report: The JAK-Inhibitor Ruxolitinib Use in Aicardi-Goutieres Syndrome Due to ADAR1 Mutation

Type I Interferonopathies comprise inherited inflammatory diseases associated with perturbation of the type I IFN response. Use of Janus kinase (JAK) inhibitors has been recently reported as possible tools for treating some of those rare diseases. We describe herein the clinical picture and treatmen...

Full description

Saved in:
Bibliographic Details
Main Authors: Marco Cattalini (Author), Jessica Galli (Author), Fiammetta Zunica (Author), Rosalba Monica Ferraro (Author), Marialuisa Carpanelli (Author), Simona Orcesi (Author), Giovanni Palumbo (Author), Lorenzo Pinelli (Author), Silvia Giliani (Author), Elisa Fazzi (Author), Raffaele Badolato (Author)
Format: Book
Published: Frontiers Media S.A., 2021-10-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items